Login / Signup

Anterior Cervical Discectomy and Fusion Using Escherichia coli -Derived Recombinant Human Bone Morphogenetic Protein-2: A Pilot Study.

Hee Jung SonBong-Soon ChangSam Yeol ChangHwan Seong ParkHyoungmin Kim
Published in: Clinics in orthopedic surgery (2022)
The outcomes of ACDF could be enhanced using 0.3 mg of E.BMP-2 with HA per segment. Based on this study, larger-scale prospective studies can be conducted to evaluate the efficacy and safety of E.BMP-2 in ACDF.
Keyphrases
  • recombinant human
  • escherichia coli
  • mesenchymal stem cells
  • bone regeneration
  • metabolic syndrome
  • cystic fibrosis
  • bone marrow
  • biofilm formation
  • insulin resistance
  • multidrug resistant